Quick View
Loading...
Generic Peptides
Estimated Delivery: 12-26 Days (International), 3-6 Days (United States)
Return within 45 Days of purchase. Duties & taxes are non-refundable.
Buy Melanotan II 5 mg and 10 mg by Generic Peptides at XSteroids. A synthetic cyclic analogue of alpha-melanocyte stimulating hormone, melanotan II activates the body's pigment machinery and additionally touches melanocortin receptors linked to appetite and sexual response. Generic Peptides supplies it as 5 mg and 10 mg lyophilized vials. This page covers the chemistry, the single small human study, the reported side effects and the honest reason regulators warn against it.
Statement of fact before anything else: Melanotan II is not approved as a medicine anywhere in the world. Health agencies advise people not to use it. Nothing on this page is a suggestion that it produces a tan safely or at all.
The molecule is a lactam bridged cyclic heptapeptide built from the alpha-MSH fragment 4 to 10, written as Ac-Nle4-Asp5-His6-D-Phe7-Arg8-Trp9-Lys10 alpha-MSH4-10-NH2. It was designed as a tanning agent on the logic that stimulating the body's own melanin production would darken skin without ultraviolet exposure.
Development as a medicine stopped in 2000 in favour of a related compound, bremelanotide, which was later approved for sexual dysfunction in women. Melanotan II is partly metabolised into that compound, which explains why the same peptide appears in both tanning and sexual health discussions.
The item shipped is a single glass vial of lyophilized powder in a 5 mg or 10 mg size, and it arrives without any diluent: bacteriostatic water is bought separately and used after delivery. It is the unapproved research peptide, not a regulated tanning medicine, and it is not sold with any labelling that states a human dose.
MC1 receptors on melanocytes drive pigment production, which is the cosmetic effect people chase. MC4, and possibly MC3, receptor activation produces the rest of the profile: appetite suppression, nausea, flushing, yawning and stretching, and spontaneous erections. Because the peptide is not selective, the side effect list was always part of the package.
A pilot phase I trial from 1996 enrolled three healthy men. Doses started at 0.01 mg per kg subcutaneously and were escalated by 0.005 mg per kg; 0.03 mg per kg caused grade II somnolence and fatigue in one of two subjects, and mild nausea appeared at most dose levels. Stretching and yawning coincided with erections lasting one to five hours after injection. Two subjects showed increased pigmentation of the face, upper body and buttocks one week after the course. The authors proposed 0.025 mg per kg daily for future phase I work. Three participants is not a safety database.
Expect very little certainty. The only controlled human data come from a 1996 pilot phase I trial in three healthy men: doses started at 0.01 mg per kg subcutaneously and escalated, 0.03 mg per kg caused grade II somnolence and fatigue in one of two subjects, and mild nausea appeared at most levels. Two subjects showed increased pigmentation of the face, upper body and buttocks about a week after the course. Three participants prove tolerability in three participants, nothing more. There is no formal human pharmacokinetic profile, so the half-life figures quoted online are secondary estimates rather than measured values. Reports of darkening moles and freckles are common, and the link to melanoma is not established: documented cases coincided with heavy sun exposure, which confounds the picture. Agencies such as the TGA advise against using these products because the dosing in them is unstable.
Mixing the 5 mg vial with 1 ml of bacteriostatic water gives 5 mg per ml, and 0.1 ml of that holds 500 mcg, the 10-unit mark on a U-100 insulin syringe. If 2 ml is used instead, the concentration falls to 2.5 mg per ml and 0.1 ml carries 250 mcg, with the same 10-unit reading. The 10 mg vial behaves identically: 2 ml for 5 mg per ml or 1 ml for 10 mg per ml. Rotate the vial gently rather than shaking it, and keep the mixed contents cold and dark.
For illustration only, the published research dose of 0.025 mg per kg would equal 2 mg for an 80 kg adult, which is 0.4 ml of a 5 mg per ml solution, or 40 units on a U-100 syringe. That arithmetic comes from a three person trial from 1996, not from a dosing guideline. No regulator has approved any amount of this peptide for human use.
If the interest is the melanocortin pathway, PT-141 (Bremelanotide) is the approved relative and the more studied molecule. For the hormonal side of libido, Kisspeptin-10 works through the gonadotropin axis instead of melanocortin receptors. Sleep focused research often pairs pigment peptides with DSIP 5 mg, because injections are taken in the evening, and neurological work pairs them with Semax 5 mg. General antioxidant support such as Glutathione 200 mg and NAD+ 250 mg is sometimes added, though none of these combinations has a published interaction study.
Melanotan II has no suppressive action on the androgen axis and calls for no post-cycle therapy. The real recovery question is monitoring rather than hormonal: because pigmentation changes affect existing moles and can produce new ones, the reported practice is to photograph and track skin changes. Any decision about a changing mole belongs to a dermatologist, not to a research protocol.
Frequently reported effects are nausea and vomiting, flushing, fatigue, yawning, stretching, appetite loss and spontaneous erections. Reversible darkening of existing moles and freckles is documented, and new naevi are part of the same picture. The 1996 study recorded nausea at most dose levels and grade II somnolence at the highest dose used.
The evidence is not settled. Reported melanoma cases in users overlapped with heavy sun exposure, and a review concluded the elevated risk is probably explained by more ultraviolet exposure and sun seeking behaviour rather than by a proven direct effect of the peptide. That is a reason to be cautious, not a clean bill of health, and the Skin Cancer Foundation advises against the substance.
Melanotan II has never been licensed. Australia's TGA has warned that tanning products containing melanotan are unapproved and inconsistently dosed, and other national agencies have issued similar notices. In sport, the peptide is not named on the WADA list but falls under the catch-all class S0 for non-approved substances, which several anti-doping bodies state explicitly.
Before mixing, the vial sits at 2 to 8 C away from light. After mixing it is kept cold in the same range and used within 28 to 30 days, the usual window for peptides because the manufacturer publishes no stability figure for the solution. Freezing the mixed vial is not advised.
Buying Melanotan II from Generic Peptides at XSteroids gives you the 5 mg or 10 mg lyophilized vial with transparent pack information on the page. Delivery runs 3 to 6 days within the United States and 12 to 26 days internationally, and the checkout is secure. We publish the regulator warnings alongside the product rather than hiding them.
It is a synthetic cyclic analogue of alpha-MSH, built from the hormone fragment 4 to 10, and it was originally developed as a tanning agent. Development was abandoned in 2000 in favour of bremelanotide. Part of melanotan is converted into that compound in the body, which is why the two are chemically related.
No. It has never been licensed in the United States, the European Union, Australia or anywhere else. The Australian TGA warns that tanning products containing melanotan are unapproved and inconsistently dosed, and the Skin Cancer Foundation advises consumers not to use the substance at all. It remains a research product.
The 5 mg vial takes 1 ml of bacteriostatic water, giving 5 mg per ml, so 0.1 ml carries 500 mcg, or 10 units on a U-100 syringe. Using two millilitres halves the strength, leaving 250 mcg in the same 10 units. Never shake the vial, and refrigerate the solution.
Nausea and vomiting, flushing, fatigue, yawning and stretching, appetite suppression and spontaneous erections are the recurring reports. The original three person study recorded nausea at most doses and grade II somnolence at 0.03 mg per kg. Darkening of existing moles and freckles is also documented, and new naevi may appear.
The link is unproven in either direction. Reported melanoma cases in users coincided with heavy sun exposure, and a review concluded the higher risk is probably explained by greater ultraviolet exposure and sun seeking behaviour. Regulators still warn against the peptide, and any changing mole needs a dermatologist rather than more research.
A 1996 pilot phase I trial dosed three healthy men from 0.01 mg per kg upward, escalating to 0.03 mg per kg, with injections on weekdays for two weeks. It reported nausea, somnolence, yawning with erections and increased pigmentation in two subjects, and suggested 0.025 mg per kg for future studies.
Melanotan II by Generic Peptides can be purchased online at XSteroids, direct from the brand catalog. Choose the 5 mg or 10 mg vial listed on this page, add it to the cart, and complete the order with secure checkout. US addresses receive orders in 3 to 6 days, and international buyers in 12 to 26 days.
Loading...
Your cart is currently empty. Let us assist you in finding the right product